Advertisement

Neuroprotektive Wirkungen des Ginkgo-biloba-Extrakts und seiner Inhaltsstoffe

  • K. Rupalla
  • H. Oberpichler-Schwenk
  • J. Krieglstein
Chapter

Zusammenfassung

Der Extrakt aus den Blättern des Ginkgo-Baumes (EGb 761) wird seit bald 30 Jahren zur Behandlung von peripheren und zerebralen Durchblutungs- und Hirnleistungsstörungen eingesetzt. Eine Vielzahl von Untersuchungen konnten pharmakologische Wirkungen des Extraktes belegen. Neben der Beschreibung der pharmakologischen Eigenschaften von EGb 761 ist es eine Zielsetzung der jüngeren Ginkgo-Forschung, diese Wirkungen definierten Bestandteilen des Gesamtextraktes, der sich aus Flavonoiden, Terpenlactonen und organischen Säuren zusammensetzt, zuzuordnen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Backhauß C, Karkoutly C, Welsch M, Krieglstein J (1992) A mouse model of focal cerebral ischemia for screening neuroprotective drug effects. J Pharmacol Meth 27: 27–32CrossRefGoogle Scholar
  2. 2.
    Bazan NG (1994) Signals, messages and genes in cerebral ischemia: novel sites for neuroprotection. In: Krieglstein J, Oberpichler H (eds) Pharmacology of Cerebral Ischemia 1994. Medpharm Scientific Publishers, Stuttgart, S 3–15Google Scholar
  3. 3.
    Baroggi N, Cachia H, Etienne A, Braquet P (1985) PAF-acether-induced cell activation studied on platelet and mast cell with flourescent probes: specific inhibition by a new antagonist, BN 52021. Prostaglandins 30: 700CrossRefGoogle Scholar
  4. 4.
    Benveniste H, Drejer J, Schousboe A, Diemer NH (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43: 1369–1374PubMedCrossRefGoogle Scholar
  5. 5.
    Braquet P, Spinnewyn B, Braquet M, Bourgain RH, Taylor JE, Etienne A, Drieu K (1985) BN 52021 and related compounds: a new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba. Blood Vessels 16: 559–572Google Scholar
  6. 6.
    Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623–634PubMedCrossRefGoogle Scholar
  7. 7.
    Clark GD, Happel LT, Zorumski CF, Bazan NG (1992) A novel presynaptic receptor that modulates the release of exicitotoxic neurotransmitters. In: Krieglstein J, Oberpichler H (eds) Pharmacology of Cerebral Ischemia 1992. Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 377–390Google Scholar
  8. 8.
    Domingo MT, Spinnewyn B, Chabrier PE, Braquet P (1988) Presence of specific binding sites for platelet-activating factor ( PAF) in brain. Biochem Biophys Res Commun 151: 730–736PubMedCrossRefGoogle Scholar
  9. 9.
    Drieu K (1986) Préparation et définition de l’extrait de Ginkgo biloba. Presse Méd 15: 1455–1457PubMedGoogle Scholar
  10. 10.
    Goracci G (1990) PAF in the nervous system: biochemistry and pathophysiology: In: Krieg’stein J, Oberpichler H (eds) Pharmacology of Cerebral Ischemia 1990. Wissenschaftliche Verlagsgesellschaft, Stuttgart S 377–390Google Scholar
  11. 11.
    Karcher L, Zagermann P, Krieglstein J (1984) Effect of an extract of Ginkgo biloba on rat brain energy metabolism in hypoxia. Naunyn-Schmiedeberg’s Arch Pharmacol 327: 31–35PubMedCrossRefGoogle Scholar
  12. 12.
    Komecki E, Ehrlich YH (1988) Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. Science 240: 1792–1794CrossRefGoogle Scholar
  13. 13.
    Krieglstein J, Beck T, Seibert A (1986) Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci 39: 2327–2334PubMedCrossRefGoogle Scholar
  14. 14.
    Krieglstein J, Ausmeier F, El-Abhar H, Lippert K, Welsch M, Rupalla K, Henrich-Noack P (1995) Neuro-protective effects of Ginkgo biloba constituents. Eur J Pharmaceutical Sci 3: 39–48CrossRefGoogle Scholar
  15. 15.
    Marcheselli VI, Rossowska MJ, Domingo MT, Braquet P, Bazan NG (1990) Distinct platelet-activating factor binding sites in synaptic endings and intracellular membranes of rat cerebral cortex. J Biol Chem 265: 9140–9145PubMedGoogle Scholar
  16. 16.
    Oberpichler H, Beck T, Abdel-Rahman M, Bielenberg GW, Krieglstein J (1988) Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. Pharmacol Res Commun 20: 349–368PubMedCrossRefGoogle Scholar
  17. 17.
    Oberpichler H, Sauer D, Roßberg C, Mennel HD, Krieglstein J (1990) PAF antagonist ginkgolid B reduces postichemic neuronal damage in rat brain hippocampus. J Cereb Blood Flow Metab 10: 133–135PubMedCrossRefGoogle Scholar
  18. 18.
    Otani M, Chatterjee SS, Gabard B, Kreutzberg GW (1986) Effect of an extract of Ginkgo biloba on triethyltin-induced cerebral edema. Acta Neuropathol 69: 54–65PubMedCrossRefGoogle Scholar
  19. 19.
    Peruche B, Oberpichler-Schwenk H, Krieglstein J (1991) Der Plättchenaktivierende Faktor (PAF) — Physiologie, Pathophysiologie, Pharmakologie. Dtsch Apoth Ztg 43: 2211–2222Google Scholar
  20. 20.
    Peter H, Fisel J, Weisser W (1966) Zur Pharmakologie der Wirkstoffe von Ginkgo biloba. Arzneimittelforsch/Drug Res 16: 719–725Google Scholar
  21. 21.
    Prehn JHM, Krieglstein J (1993) Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J Neurosci Res 34: 179–188PubMedCrossRefGoogle Scholar
  22. 22.
    Sakaruda O, Kennedy C, Jehle J, Brown JD, Carbin GL, Sokoloff L (1978) Measurement of local cerebral blood flow with iodo-C14-antipyrine. Am J Physiol 234: 59–66Google Scholar
  23. 23.
    Sancesario G, Kreutzberg GW (1986) Stimulation of astrocytes affects cytotoxic brain edema. Acta neuropathol 72: 3–14PubMedCrossRefGoogle Scholar
  24. 24.
    Siesjö B (1991) The role of calcium in cell death. In: Price D, Aguayo A, Thoenen H (eds) Neurodegenerative Disorders: Mechanisms and Prospects for Therapy. Wiley & Sons, Chichester, PP 35–59Google Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1995

Authors and Affiliations

  • K. Rupalla
    • 1
  • H. Oberpichler-Schwenk
    • 1
  • J. Krieglstein
    • 1
  1. 1.Institut für Pharmakologie und ToxikologiePhilipps-Universität MarburgMarburgDeutschland

Personalised recommendations